Does Aetna Cover ADHD Treatment in Florida? A 2026 Guide

Last updated: September 2, 2026

Aetna commercial plans in Florida may cover ADHD evaluation, follow-up, and some stimulant or non-stimulant medications when the visit is medically necessary, in network, and allowed on your medical policy and CVS/Caremark list. Coverage is not automatic. Federal MHPAEA and Fla. Stat. § 627.668 set a floor for many fully insured policies. Always verify your own benefits before you book.

See if you may qualify for online ADHD evaluation through Klarity’s network of 2,000+ licensed providers. You can also learn about ADHD care or browse conditions we treat.

TLDR

• Aetna may cover medically necessary ADHD visits and some ADHD drugs in Florida. Benefits vary by employer PPO/HMO, Florida Marketplace, Medicare Advantage, and Medicaid managed care products.
• Federal MHPAEA plus Fla. Stat. § 627.668 (optional/make-available mental health coverage on many fully insured policies) apply to many commercial products. They do not rewrite self-funded ERISA plan documents or Medicare Advantage formularies. § 627.668 is not a stimulant guarantee.
• Florida Statutes § 456.47 governs telehealth practice. It does not force Aetna to pay every video visit. Coverage still depends on the plan.
• Pharmacy benefits typically run through CVS/Caremark. Stimulants (methylphenidate, amphetamine salts, lisdexamfetamine) often need prior authorization, quantity limits, and generic-first steps. Do not confuse Caremark with Express Scripts (Cigna) or Carelon Rx (Anthem).
• HHS/DEA telemedicine flexibilities for prescribing many controlled medications currently run through December 31, 2026. ADHD stimulants are Schedule II. Atomoxetine, viloxazine, and guanfacine ER are typically not Schedule II.
• Cigna PA Policy IP0477 (effective May 15, 2026 on many Cigna commercial lists) is a Cigna/ESI stimulant rule. It does not control Aetna/Caremark ADHD drugs.
• CVS/Caremark Zepbound timing (July 1, 2025 removal / October 1, 2026 reinstatement on many lists) is an obesity/GLP-1 story. It does not decide ADHD stimulant coverage.
• Medicare GLP-1 Bridge ($50/month Wegovy/Zepbound/Foundayo via CMS) is a Medicare obesity program. It does not pay for ADHD medications on Aetna commercial plans.
• Verify benefits on Aetna member tools and Caremark. For many fully insured Florida complaints, Florida DFS Division of Consumer Services / FLOIR consumer help is often 1-877-693-5236 (1-877-MY-FL-CFO). Medicare Advantage appeals follow CMS, then often Maximus IRE at 1-855-887-6668. AHCA/Medicaid products follow Florida Medicaid rules, not this commercial page. If you are in crisis, call or text 988.

Disclaimer: This article is educational. It is not a benefits determination, diagnosis, or guarantee of payment. Coverage varies by plan. Verify benefits with Aetna and your clinician before you book.

Does Aetna cover ADHD treatment in Florida?

Often, some of it, with caveats. Evaluation visits and medication management may process as medical or behavioral health benefits on many Aetna commercial plans when the visit is medically necessary and in network. Medication is a separate pharmacy question. Copays, deductibles, and whether Klarity is in network still sit in your Summary of Benefits and Coverage, medical policy, and Caremark drug list.

Self-funded ERISA employer plans follow federal rules and the plan document more than Fla. Stat. § 627.668. Medicare Advantage, Medicaid, and dual-eligible products follow CMS and Florida Medicaid rules, not § 627.668 in the same way. Always treat this page as education, not a coverage determination.

Do not mix Aetna with Florida Blue (Blue Cross and Blue Shield of Florida), Anthem, or Cigna. Related Florida guides: Cigna Florida ADHD, Anthem Florida ADHD, Cigna Florida anxiety, and Anthem Florida anxiety.

Check if your plan may cover an ADHD visit.

How common is ADHD?

According to the National Institute of Mental Health, the estimated lifetime prevalence of ADHD in U.S. adults aged 18 to 44 years was 8.1%. According to the CDC, an estimated 7 million (11.7%) U.S. children aged 3-17 years have a current ADHD diagnosis.

Those figures describe national epidemiology. They do not decide whether your Aetna Florida plan pays for a video visit or a brand-name stimulant.

Parity in Florida: what § 627.668 does and does not do

Two layers matter in 2026:

1. Federal MHPAEA. Group health plans and many individual plans that cover mental health generally cannot apply more restrictive financial requirements or treatment limitations than they apply to medical/surgical care in the same classification.
2. Fla. Stat. § 627.668 addresses optional/make-available coverage for mental and nervous disorders on many fully insured policies written in Florida. See the statute text on Online Sunshine. It is a make-available mental health rule, not a mandate that every methylphenidate, amphetamine, or lisdexamfetamine product must sit on a preferred tier.

Parity does not mean every stimulant is preferred or that prior authorization is illegal. It means the plan generally cannot make ADHD care harder to use than comparable medical care in the same classification. If Aetna denies a brand stimulant after a generic alternative exists, that is often a formulary or PA issue, not an automatic parity violation. If the denial is a blanket mental-health visit cap that medical visits do not face, parity may apply. Keep those buckets separate when you appeal.

Florida DFS Division of Consumer Services contact: myfloridacfo.com/division/consumers/contactus. Helpline: 1-877-693-5236.

Telehealth ADHD visits and controlled-substance rules

Florida Statutes § 456.47 sets practice standards for telehealth. It does not rewrite Aetna’s medical policy or Caremark’s PA rules. Employer self-funded plans may still reimburse video visits, but § 627.668 and § 456.47 may not bind them the same way.

Klarity providers licensed in Florida can evaluate ADHD by video when clinically appropriate. Same-day appointments are often available. Coverage still depends on network status and cost share.

Federal controlled-substance telemedicine rules remain a separate overlay. HHS and DEA have extended certain telemedicine flexibilities through December 31, 2026. Stimulants remain Schedule II. Your clinician still must follow DEA, Florida prescriber, EPCS, and plan rules. Florida Prescription Drug Monitoring Program review may apply before some controlled prescriptions.

How CVS/Caremark usually treats ADHD drugs

Check your 2026 list on Aetna member tools and Caremark. Plans often:

• Require PA for methylphenidate, mixed amphetamine salts, lisdexamfetamine, and related stimulants
• Prefer certain generics before brand Concerta, Vyvanse, or Adderall XR
• Cover atomoxetine, guanfacine ER, clonidine ER, or bupropion on different tiers when medically necessary
• Apply quantity limits and documentation (age of diagnosis, rating scales, cardiac history, substance-use screening)

Klarity clinicians can help you understand what a PA packet often includes. They cannot promise Aetna will approve a drug. Do not confuse Caremark with Express Scripts IP0477 (Cigna) or Humana Pharmacy Solutions (typical Medicare Advantage).

Zepbound’s Caremark timeline (removed from many lists July 1, 2025; reinstated on many lists October 1, 2026) is an obesity drug story. It does not tell you whether Adderall, Concerta, or Vyvanse is preferred on your ADHD benefit.

Aetna’s medication lookup and Caremark member tools are the source of truth for your NDC.

Medicare Advantage, Medicaid, and dual-eligible members

This page describes commercial Aetna coverage in Florida. Aetna Medicare Advantage products follow CMS 42 CFR Part 422, the plan’s Part D formulary, and CMS appeal rules, not Fla. Stat. § 627.668 in the same way. After plan reconsideration, many MA appeals go to Maximus IRE at 1-855-887-6668.

The Medicare GLP-1 Bridge ($50/month Wegovy/Zepbound/Foundayo via CMS, starting July 1, 2026 on eligible Medicare obesity pathways) does not pay for ADHD stimulants.

Florida Medicaid and AHCA managed-care products, including dual-eligible members, follow Florida Medicaid rules. Do not use this commercial Aetna page as a Medicaid coverage map.

How to verify benefits before you book

1. Log in to Aetna member tools and confirm medical vs behavioral health visit copays for telehealth psychiatry.
2. Search Caremark for your stimulant or non-stimulant NDC, tier, PA flag, and quantity limit.
3. Ask whether Klarity or the specific Florida-licensed clinician is in network for your product.
4. If Aetna denies a visit or drug, request the denial in writing and compare it to medical/surgical limits in the same classification (MHPAEA).
5. For many fully insured Florida complaints, call DFS/FLOIR consumer help at 1-877-693-5236. Self-funded ERISA plans often go through the employer and federal DOL, not DFS.

See if you may qualify for online ADHD care. If you are in crisis, call or text 988.

FAQ

Will Aetna pay for an ADHD video visit in Florida?

It may, when the visit is medically necessary, in network, and allowed on your medical or behavioral health policy. § 456.47 does not force payment. Verify telehealth cost share on your SBC.

Does Fla. Stat. § 627.668 guarantee stimulant coverage?

No. It is a make-available mental health coverage rule on many fully insured policies. It is not a mandate that Aetna must prefer every brand stimulant.

Is Cigna IP0477 Aetna’s ADHD PA rule?

No. IP0477 is a Cigna/Express Scripts stimulant PA policy. Aetna typically uses Caremark PA criteria instead.

Does the Caremark Zepbound change affect ADHD drugs?

Usually no. That timeline is about obesity GLP-1s. Check your ADHD NDC separately.

Can Klarity prescribe stimulants by telehealth in Florida?

A Florida-licensed clinician may prescribe when clinically appropriate and when DEA, Florida, EPCS, and plan rules allow it. HHS/DEA flexibilities currently run through December 31, 2026. Coverage is still a separate Aetna/Caremark question.

Browse conditions we treat or check if your plan may cover an ADHD visit.